Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.24.1.1.u2
Stockholders’ Equity (Details Narrative) - USD ($)
9 Months Ended
Nov. 13, 2023
Sep. 28, 2022
Mar. 31, 2024
Mar. 31, 2023
Nov. 20, 2023
Nov. 19, 2023
Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]              
Common stock, authorized     50,000,000   50,000,000 40,000,000 40,000,000
Common stock, par value     $ 0.001   $ 0.001   $ 0.001
preferred stock, authorized     2,000,000   2,000,000   2,000,000
Preferred stock, par value     $ 0.001   $ 0.001   $ 0.001
Financing fees     $ 62,354 $ 248,927      
Loan And Security Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of common stock 300,000            
Private Placement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of common stock   2,264,650          
Stock issued during period, value, new issues   $ 6,600,000          
Stock issued value per unit   $ 2.935          
Proceeds from issuance or sale of equity   $ 6,300,000          
Financing fees   $ 300,000          
Warrant exercise price per share   $ 4.215